Search
Call for Speakers: INCB Civil Society Hearing 2024
We are looking for civil society experts wishing to speak at this years INCB Civil Society Hearing
Topic: “scenarios and possible responses to the rapid expansion of synthetic drug manufacture, trafficking, marketing and consumption”
...Acelerar los Sistemas de Prevención en las Políticas sobre Drogas: nuevas iniciativas
Strategies in Media and Social Media for Substance Use Prevention
Cannabis Use Linked to Elevated Myocardial Infarction and Stroke Risk
Alcohol intake app Drink Less could cut down unhealthy drinking, say scientists
Drug market trends of Cocaine, Amphetamine-type stimulants and New Psychoactive Substances
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
It contains an analysis of the global market for cocaine...
Stimulants: health and social responses
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview of what to consider when planning or delivering health and social responses to stimulant...
Call for Speakers for the CND High-Level Segment in March 2024
The Commission on Narcotic Drugs (CND) will hold on 14-15 March 2024 a High Level Segment to conduct the 2024 Mid-Term Review. The Review will focus on taking stock of the implementation of all existing international drug policy commitments...
WAVE opportunities to attend Lisbon Addictions 2024
WAVE Bursaries to attend Lisbon Addictions 2024
CIJ INFORMA 101
La Revista CIJ Informa, es publicada por Centros de Integración Juvenil, (CIJ) Institución anfitriona del Capítulo ISSUP México 🇲🇽. En ella podrán enterarse de las diferentes actividades realizadas desde la Institución, el Capítulo Nacional...
2024 NIDA International Forum: Call for Research Poster Abstracts and Travel Award Requests
Call for Research Poster Abstract Submissions and Travel Award Requests
Submission Deadline: January 14, 2024
Present your international drug use and addiction research during the 2024 NIDA International Forum, which will be held June...
Open Consultation: UK clinical guidelines for alcohol treatment
The consultation on the UK clinical guidelines for alcohol treatment is now open.
Consultation description
This consultation asks you to review individual chapters from the draft UK clinical guidelines for alcohol treatment.
Each...
Lisbon Addictions 2024: Call for abstracts
Lisbon Addictions 2024 is a multidisciplinary conference that provides both a forum for networking and an opportunity to showcase cutting-edge research. The conference is intended to inform policy development and practice through a better...
Contribute to the 2024 CND Mid-term Review
RESPOND TO THE ONLINE CONSULTATION
The global survey is part of a broader consultation process in preparation for the 2024 Mid-term review of the Commission on Narcotic Drugs. It aims to gather inputs from NGOs working on drug...
Тогодағы Бүкіләлемдік есірткі күні
26 маусымды мерекелеу аясында...
РАПАА ҮЕҰ... CNAD мүшесінің қатысуымен La Poz de la TVT телевизиялық бағдарламасында өтуді жүзеге асырды
Кеше, 26 маусымда RAPAA ҮЕҰ ПНАПП мүшесінің қатысуымен Эве тілінде бағдарлама өткізді
Бұл күні...
Support. Don't Punish International Day of Action
A global advocacy campaign calling for drug policies based on health and human rights.
Support. Don’t Punish is a global grassroots-centred initiative in support of harm reduction and drug policies that prioritise public health and human...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member